Lymphomas are caused by an abnormal proliferation of white blood cells and can occur at any age.  A clinical trial has shown that patients with a specific molecular subtype of diffuse large B-cell lymphoma (DLBCL) are more likely to respond to the drug ibrutinib (Imbruvica) than patients with another molecular subtype of the disease. The study appeared online July 20, 2015, in Nature Medicine.

Related posts:

  1. Medicare Card, Circulating tumor DNA in blood can predict recurrence of the most common type of lymphoma Medicare Card, Circulating tumor DNA in blood can predict recurrence of the most common type of lymphoma...
  2. Medicare Card, Study identifies novel genomic changes in the most common type of lung cancer Medicare Card, Study identifies novel genomic changes in the most common type of lung cancer...
  3. Medicare, NIH scientists identify possible gene target for treating a form of lymphoma Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent genetic abnormalities in a form of cancer known as diffuse large B cell lymphoma. MYD88 encodes a […]...
  4. Patient-derived stem cells could improve drug research for Parkinson’s Researchers have taken a step toward personalized medicine for Parkinson’s disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health....
  5. Medicare Card, NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer Medicare Card, NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer...
  6. Scientists find approach to enhance and prolong immune attack against tumor cells Investigators have identified a new class of human immune cells that behave like stem cells. These cells, a subtype of T lymphocytes, which comprise a small fraction of white blood cells, may prove more effective than any previously reported type of T cell for treating tumors. The study, by scientists at the National Cancer Institute […]...
  7. Medicare Card, Study shows colon and rectal tumors constitute a single type of cancer Medicare Card, Study shows colon and rectal tumors constitute a single type of cancer...
  8. Medicare Card, NIH announces the launch of 3 integrated precision medicine trials The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, was launched today to identify early-stage lung cancer patients with tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those changes can lead to improved survival....
  9. Medicare Card, NIH study finds extreme obesity may shorten life expectancy up to 14 years Adults with extreme obesity have increased risks of dying at a young age from cancer and many other causes including heart disease, stroke, diabetes, and kidney and liver diseases, according to results of an analysis of data pooled from 20 large studies of people from three countries. The study, led by researchers from the National […]...
  10. Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
  11. Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
  12. Medicare Card, NIH study uncovers a starring role for supporting cells in the inner ear Medicare Card, NIH study uncovers a starring role for supporting cells in the inner ear...
  13. Medicare Card, NIH-developed candidate dengue vaccine shows promise in early-stage trial Medicare Card, NIH-developed candidate dengue vaccine shows promise in early-stage trial...
  14. Medicare Card, Common treatment for patients with chronic, progressive lung disease found to be ineffective Medicare Card, Common treatment for patients with chronic, progressive lung disease found to be ineffective...
  15. Medicare Mouse study shows effect of blood pressure drug on Alzheimer’s disease A drug used decades ago to treat high blood pressure has been shown to improve learning and memory in mouse models of Alzheimer’s disease, according to a new study by researchers at the National Institute on Aging (NIA), part of the National Institutes of Health. The study found that the drug, diazoxide, acted on nerve […]...